U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Sildenafil citrate chewing gum formulations and methods of using the same

Patent 6592850 Issued on July 15, 2003. Estimated Expiration Date: Icon_subject September 19, 2021. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

1298670

1629461

2892753

2990328

3011949

3029189

3047461

3075884

3196172

3308022

More ...

Inventors

Assignee

Application

No. 956445 filed on 09/19/2001

US Classes:

424/48, CHEWING GUM TYPE424/440, Candy, candy coated or chewing gum424/489Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)

Examiners

Primary: Page, Thurman K.
Assistant: Howard, S.

Attorney, Agent or Firm

Foreign Patent References

  • 2001/0036445 Antanikar. 11/13/2012
  • 2002/0012633 Gmunder et al. 01/13/2012
  • 2002/0022057 Battery et al. 02/13/2012
  • 2002/0039560 Ream et al. 04/13/2012
  • 0202819 EP. 11/13/1986
  • 0217109 EP. 04/13/1987
  • 0 221 850 EP. 05/13/1987
  • 0239541 EP. 09/13/1987
  • 0371584 EP. 06/13/1990
  • 0 273 809 EP. 07/13/1998
  • 2345938 FR. 03/13/1976
  • 2 635 441 FR. 02/13/1990
  • 2706771 FR. 06/13/1993
  • 0 934 596 GB. 08/13/1963
  • 0 963 518 GB. 07/13/1964
  • 1 489 832 GB. 10/13/1977
  • 2181646 GB. 04/13/1987
  • 43 42 568 GB. 06/13/1994
  • 01293655 IT. 07/13/1997
  • 02173487 IT. 07/13/1997
  • 91-112450 JP. 09/13/1989
  • 91-251533 JP. 11/13/1991
  • 94-303911 JP. 11/13/1994
  • 96-19370 JP. 01/13/1996
  • 86/242561 JP. 10/13/1996
  • 94-2868 KR. 04/13/1994
  • 84/02271 WO. 06/13/1984
  • 90/12511 WO. 11/13/1990
  • 90/12583 WO. 11/13/1990
  • 92/06680 WO. 04/13/1992
  • 95/00038 WO. 01/13/1995
  • 95/00039 WO. 01/13/1995
  • 95/10290 WO. 04/13/1995
  • 96/00070 WO. 01/13/1996
  • 96/03975 WO. 02/13/1996
  • 97/21424 WO. 06/13/1997
  • 97/24036 WO. 07/13/1997
  • 98/23165 WO. 06/13/1998
  • 98/23166 WO. 06/13/1998
  • 98/23167 WO. 06/13/1998
  • WO 99/27798 WO. 06/13/1999
  • 99/33352 WO. 07/13/1999
  • 99/44436 WO. 09/13/1999
  • 00/13523 WO. 03/13/2012
  • 00/35296 WO. 06/13/2012
  • 00/35298 WO. 06/13/2012
  • 00/38532 WO. 07/13/2012
  • 02/13781 WO. 02/13/2012

International Classes

A61K 009/68
A61K 009/16

Foreign Application Priority Data

1999-12-14 WO

Abstract

Methods and chewing gum formulations for delivering a medicament, namely sildenafil citrate, to an individual are provided. Further, an improved dosage form and method of treating erectile dysfunction are provided. Methods of treating esophageal spasms, dysphagia, and gastroparesis utilizing chewing gum formulations containing sildenafil citrate are also provided.

Other References

  • Beckett, A.H., et al.; "Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes" (1967) J. Pharm. Pharmac., 19 Suppl. 31S-41S
  • Weinberg, David S., et al.; "Sublingal absorption of selected opioid analgesics" (1988) Clin. Pharmacol Ther., 44: 335-342
  • U.S. patent application Ser. No. 09/286,818, Ream et al., filed Apr. 6, 1999
  • U.S. patent application Ser. No. 09/421,095, Ream et al., filed Oct. 20, 1999
  • U.S. patent application Ser. No. 09/510,878, Ream et al., filed Feb. 23, 2000
  • U.S. patent application Ser. No. 09/535,458, Ream et al., filed Mar. 24, 2000
  • U.S. patent application Ser. No. 09/522,290, Song et al., filed Apr. 19, 2000
  • U.S. patent application Ser. No. 09/591,256, Zyck et al., filed Jun. 9, 2000
  • U.S. patent application Ser. No. 09/592,400, Ream et al., filed Jun. 13, 2000
  • U.S. patent application Ser. No. 09/618,808, Ream et al., filed Jul. 18, 2000
  • U.S. patent application Ser. No. 09/621,643, Johnson et al., field Jul. 21, 2000
  • U.S. patent application Ser. No. 09/621,780, McGrew et al., filed Jul. 21, 2000
  • U.S. patent application Ser. No. 09/631,326, Ream et al., filed Aug. 3, 2000
  • U.S. patent application Ser. No. 09/651,514, Tyrpin et al., filed Aug. 30, 2000
  • U.S. patent application Ser. No. 09/653,669, Zyck et al., filed Sep. 1, 2000
  • U.S. patent application Ser. No. 09/654,464, Zyck et al., filed Sep. 1, 2000
  • U.S. patent application Ser. No. 09/671,552, Ream et al., filed Sep. 27, 2000
  • U.S. patent application Ser. No. 09/681,935, Seielstad et al., filed Jun. 28, 2001
  • U.S. patent application Ser. No. 09/714,571, Gmunder et al., filed Nov. 16, 2000
  • U.S. patent application Ser. No. 09/747,300, Zyck et al., filed Dec. 22, 2000
  • U.S. patent application Ser. No. 09/747,323, Zyck et al., filed Dec. 22, 2000
  • U.S. patent application Ser. No. 09/748,699, Zyck et al., filed Dec. 22, 2000
  • U.S. patent application Ser. No. 09/749,983, Urnezis et al., filed Dec. 27, 2000
  • U.S. patent application Ser. No. 09/759,561, Ream et al., filed Jan. 11, 2001
  • U.S. patent application Ser. No. 09/759,838, Ream et al., filed Jan. 11, 2001
  • U.S. patent application Ser. No. 09/924,914, Ream et al., filed Aug. 8, 2001
  • Akitoshi et al., Abstract "Acceleration of Transdermal Absorption of Pharmaceuticals by Essential Oils and Organic Solvents," Chem. Abst., 112:125228t, 1990
  • Adams, M.W., d-Alpha Tocopheryl Polyethylene glycol 1000 Succinate (Eastman vitamin E TPGS) as an Emulsifier and Bioenhancer for Drugs and Lipophilic Compounds, 6th International Conference on Pharmaceutical Technology, Paris, Jun. 2-4, 1992
  • Allen, et al., "Exclusive Guide to Wellness Foods and Nutraceuticals", Food Processing (Special Supplement), (Mar., 1999)
  • Bradford, A Rapid and Sensitive Method for the Quantification of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding, Analytical Biochemistry, 72:248-254 (1976)
  • Broihier, Kitty R.D., "Foods of Tomorrow, Milking The Nutrition Market", Food Processing, (Mar., 1999), pp. 41, 42, and 44
  • Broihier, Kitty R.D., "Tea Time For Nutraceuticals, New Black, Green Tea Products Brew Up a Bevy Of Health Benefits", Food Processing; (Mar., 1999), pp. 59, 61, and 63
  • Calanchi et al., "Taste-masking of oral formulations", Eurand International SpA, Pharmaceutical Manufacturing International, 1996 (5 pages)
  • Chang et al., "The Effect of Water-Soluble Vitamin E on Cyclosporine Pharmacokinetics in Healthy Volunteers," Abstract in American Society to Clinical Pharmacology and Therapeutics, 57(2):163, Feb. 1995
  • Elliott, James G., "Application of Antioxidant Vitamins in Foods and Beverages" Food Technology, (Feb., 1999), pp. 46-48
  • The Eurand Group, Brochure (undated) (published at least before Nov. 27, 1996), (16 pages)
  • "Flavor Encapsulation Technologies, Flavor Unit Sweet, Product Management", H&R (undated) (published at least before Nov. 27, 1996), 25 pages
  • Gumtech article from the internet "Customized Solutions For Customer Brands", printed Oct. 18, 2000, , 3 pages
  • Hebert, Mary F. et al.; "Bioavailability of Cyclosporine with Concomitant Rifampin Administration is Markedly Less Than Predicted by Hepatic Enzyme Induction" (1992) Clin. Pharmacol. Ther. 52:453-457
  • Heritage Consumer Products Co. article from the Internet "Cosmetics and Toiletries, The Heritage Story", printed Jul. 20, 2000, , 1 page
  • Kronbach, Thomas et al.; "Oxidation of Midazolam and Triazolam by Human Liver Cytochrome P450IIIA4" (1989) Molec. Pharm. 36:89-96
  • Lalka et al.; "The Hepatic First-Pass Metabolism of Problematic Drugs" (1993) J. Clin. Pharmacol. 33:657-669
  • Lum et al., "Clinical Trials of Modulation of Multidrug Resistance. Pharmacokinetic and Pharmacodynamic Considerations" (1993) Cancer 72:3502-3514
  • Merck Index, 11th Ed., #1635 "Caffeine" (1989), p. 248
  • Merck Index, 12th Ed., #2337 "Cimetidine" (1996), p. 383
  • Merck Index, 12th Ed., #3264 "Dimethicone" (1996), p. 544
  • Merck Index, 12th Ed., #3972 "Famotidine" (1996), p. 667
  • Merck Index, 12th Ed., #6758 "Nizatidine" (1996), p. 1143
  • Merck Index, 12th Ed., #6977, "Omerprazole" (1996), p. 1174
  • Merck Index, 12th Ed., #8272 "Rabeprazole" (1996), p. 1392
  • Merck Index, 12th Ed., #8286 "Ranitidine" (1996), p. 1395
  • Muranishi, Shozo; "Absorption Enhancers" (1990) Crit. Rev. Ther. Drug Carriers Sys., 7:1-33
  • Neilsen et al., P-Glycoprotein as Multidrug Transporter: A Critical Review of Current Multidrug Resistant Cell Lines, Chimica et Biophysica Acta., 1139:169-183 (1992)
  • Product package "Aspergum" distributed by Heritage Consumer Products, LLC (on sale prior to Nov. 27, 1995)
  • Product package "BreathAsure Dental Gum" distributed by Breath Asure, Inc. (1998)
  • Product package "Chew & Sooth Zinc Dietary Supplement Gum" by Gumtech International, Inc. (undated)
  • Product package "CHOOZ Antacid/Calcium Supplement with Calcium Carbonate" distributed by Heritage Consumer Products Co
  • Product package "Dental Care the Baking Soda Gum" distributed by Church & Dwight Co., Inc. (1998)
  • Product package "Trident Advantage with Baking Soda" distributed by Warner-Lambert Co. (1998)
  • Product package for Stay Alert Caffeine Supplement Gum, distributed by Amurol Confections Company (first quarter 1998)
  • Rabeprazole article from the Internet "Raberprazole: Pharmacokinetics and Safety in the Elderly", printed Sep. 22, 2000,, 2 pages
  • Somberg et al.; "The Clinical Implications of First-Pass Metabolism: Treatment Strategies for the 1990's" (1993) J. Clin. Pharmacol. 33:670-673
  • Specialty Minerals Inc. Brochure, Apr. 1998, 19 pages
  • Tam, Yun K.; "Individual Variation in First-Pass Metabolism" (1993) Clin. Pharmacokinet. 25:300-328
  • The United States Pharmacopeia The National Formulary--"General Information", dated Jan. 1, 1990 pp. 1624-1625 and pp. 1696-1697
  • Van Hoogdalem et al.; "Intestinal Drug Absorption Enhancement: An Overview" (1989) Pharmacol. Ther. 44:407-443
  • Vreeland, C. Curtis, "Nutraceuticals Fuel Confectionery Growth" Candy R&D, (Mar., 1999), pp. 29, 31-32, 34-35
  • Warren et al.; "Increased Accumulation of Drugs in Multidrug-Resistant Cell Induced by Liposomes" (1992) Cancer Research 52:3241-3245
  • Watkins, Paul B.; "The Role of Cytochromes P-450 in Cyclosporine Metabolism" (1990) J. Am. Acad. Dermacol. 23:1301-1309
  • Wrighton et al.; "In Vitro Methods for Assessing Human Hepatic Drug Metabolism: Their Use in Drug Development" (1993) 25:453-484
  • Wu et al.; "Use of IV and Oral Drug Levels from Cyclosporene (CsA) with Concomitant Rifampin to Differentiate Gut Absorption and Metabolism" (1993) Pharm. Res. 10:abstract ppdm8185
  • Zamora et al.; "Physical-Chemical Properties Shared by Compounds that Modulate Multidrug Resistance in Human Loukemic Cells" (1988) Molec. Pharmacol. 33:454-46
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?